The anti-tumor effect of ursolic acid on papillary thyroid carcinoma via suppressing Fibronectin-1

References

• Liu F, Lou K, Zhao X, et al. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10. Int J Mol Med. 2018;42(6):3027–3036.
   PubMed Web of Science ®Google Scholar
• Abdullah MI, Junit SM, Ng KL, et al. Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci. 2019;16(3):450–460.
   PubMed Web of Science ®Google Scholar
• Li M, Chai H-F, Peng F, et al. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma. Cell Death Dis. 2018;9(11):1120.
   PubMedGoogle Scholar
• Mlala S, Oyedeji AO, Gondwe M, et al. Ursolic acid and its derivatives as bioactive agents. Molecules. 2019;24(15).
   PubMed Web of Science ®Google Scholar
• Achiwa Y, Hasegawa K, Komiya T, et al. Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells. Oncol Rep. 2005;13(1):51–57.
   PubMed Web of Science ®Google Scholar
• Sultana N. Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J Enzyme Inhib Med Chem. 2011;26(5):616–642.
   PubMed Web of Science ®Google Scholar
• Zerin T, Lee M, Jang WS, et al. Anti-inflammatory potential of ursolic acid in Mycobacterium tuberculosis-sensitized and concanavalin A-stimulated cells. Mol Med Rep. 2016;13(3):2736–2744.
   PubMed Web of Science ®Google Scholar
• Kim K, Shin EA, Jung JH, et al. Ursolic acid induces apoptosis in colorectal cancer cells partially via upregulation of MicroRNA-4500 and inhibition of JAK2/STAT3 phosphorylation. Int J Mol Sci. 2018;20(1).
   Web of Science ®Google Scholar
• Aguiriano-Moser V, Svejda B, Li Z-X, et al. Ursolic acid from Trailliaedoxa gracilis induces apoptosis in medullary thyroid carcinoma cells. Mol Med Rep. 2015;12(4):5003–5011.
   PubMed Web of Science ®Google Scholar
• Goossens K, Van Soom A, Van Zeveren A, et al. Quantification of fibronectin 1 (FN1) splice variants, including two novel ones, and analysis of integrins as candidate FN1 receptors in bovine preimplantation embryos. BMC Dev Biol. 2009;9:1.
   PubMed Web of Science ®Google Scholar
• Missirlis D, Haraszti T, Kessler H, et al. Fibronectin promotes directional persistence in fibroblast migration through interactions with both its cell-binding and heparin-binding domains. Sci Rep. 2017;7(1):3711.
   PubMedGoogle Scholar
• Xia S, Wang C, Postma EL, et al. Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis. Onco Targets Ther. 2017;10:1743–1755.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhao C, Ye Y, et al. High expression of fibronectin 1 indicates poor prognosis in gastric cancer. Oncol Lett. 2020;19(1).
   Web of Science ®Google Scholar
• Sponziello M, Rosignolo F, Celano M, et al. Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells. Mol Cell Endocrinol. 2016;431:123–132.
   PubMed Web of Science ®Google Scholar
• Xu C-G, Zhu X-L, Wang W, et al. Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo. Pharm Biol. 2019;57(1):169–175.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 Dec;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71(10):1397–1421.
   PubMed Web of Science ®Google Scholar
• Hill RA, Connolly JD. Triterpenoids. Nat Prod Rep. 2013;30(7):1028–1065.
   PubMed Web of Science ®Google Scholar
• Wu -C-C, Huang Y-F, Hsieh C-P, et al. Combined use of zoledronic acid augments ursolic acid-induced apoptosis in human osteosarcoma cells through enhanced oxidative stress and autophagy. Molecules. 2016;21(12):1640.
   Web of Science ®Google Scholar
• Kashyap D, Tuli HS, Sharma AK. Ursolic acid (UA): a metabolite with promising therapeutic potential. Life Sci. 2016;146:201–213.
   PubMed Web of Science ®Google Scholar
• Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, et al. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis. 2017;22(6):800–815.
   PubMed Web of Science ®Google Scholar
• Yu Y-X, Gu Z-L, Yin J-L, et al. Ursolic acid induces human hepatoma cell line SMMC-7721 apoptosis via p53-dependent pathway. Chin Med J. 2010;123(14):1915–1923.
   PubMed Web of Science ®Google Scholar
• Bonaccorsi I, Altieri F, Sciamanna I, et al. Endogenous reverse transcriptase as a mediator of ursolic acid’s anti-proliferative and differentiating effects in human cancer cell lines. Cancer Lett. 2008;263(1):130–139.
   PubMed Web of Science ®Google Scholar
• Zhou M, Liu X, Li Z, et al. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int J Cancer. 2018;143(4):921–930.
   PubMed Web of Science ®Google Scholar
• Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786–801.
   PubMed Web of Science ®Google Scholar
• Cao L, Nicosia J, Larouche J, et al. Detection of an integrin-binding mechanoswitch within fibronectin during tissue formation and fibrosis. ACS Nano. 2017;11(7):7110–7117.
   PubMed Web of Science ®Google Scholar
• Xiao J, Yang W, Xu B, et al. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. BMC Cancer. 2018;18(1):976.
   PubMedGoogle Scholar
• Chen HB, Zheng HT. MicroRNA-200c represses migration and invasion of gastric cancer SGC-7901 cells by inhibiting expression of fibronectin 1. Eur Rev Med Pharmacol Sci. 2017;21(8):1753–1758.
   PubMed Web of Science ®Google Scholar
• Qian P, Zuo Z, Wu Z, et al. Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res. 2011;71(20):6463–6474.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang L, Liu Z, et al. iTRAQ-coupled 2D LC/MS-MS analysis of CXCR7-transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers. Oncol Lett. 2017;14(3):3734–3740.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhuang J, Wang G, et al. MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression. Oncol Lett. 2017;14(6):7799–7806.
   PubMed Web of Science ®Google Scholar
• Terry S, Chouaib S. EMT in immuno-resistance. Oncoscience. 2015;2(10):841–842.
   PubMedGoogle Scholar
• Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14(10):611–629.
   PubMed Web of Science ®Google Scholar
• Sun L, Fang J. Epigenetic regulation of epithelial-mesenchymal transition. Cell Mol Life Sci. 2016;73(23):4493–4515.
   PubMed Web of Science ®Google Scholar
• Lotfi A, Mohammadi G, Tavassoli A, et al. Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2015;16(4):1327–1330.
   PubMedGoogle Scholar
• Sun L, Zhang Y, Lou J. ARHGAP9 siRNA inhibits gastric cancer cell proliferation and EMT via inactivating Akt, p38 signaling and inhibiting MMP2 and MMP9. Int J Clin Exp Pathol. 2017;10(12):11979–11985.
   PubMed Web of Science ®Google Scholar
• Yuan S-M. α-smooth muscle actin and ACTA2 gene expressions in vasculopathies. Braz J Cardiovasc Surg. 2015;30(6):644–649.
   PubMedGoogle Scholar
• Ding L, Zhang Z, Shang D, et al. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. J Oral Pathol Med. 2014;43(5):335–343.
   PubMed Web of Science ®Google Scholar
• Liao YX, Zhang ZP, Zhao J, et al. Effects of fibronectin 1 on Cell proliferation, senescence and apoptosis of human glioma cells through the PI3K/AKT signaling pathway. Cell Physiol Biochem. 2018;48(3):1382–1396.
   PubMedGoogle Scholar
• Li B, Shen W, Peng H, et al. Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT. Onco Targets Ther. 2019;12:3207–3221.
   PubMed Web of Science ®Google Scholar
• Wang EM, Fan QL, Yue Y, et al. Ursolic acid attenuates high glucose-mediated mesangial cell injury by inhibiting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway. Med Sci Monit. 2018 Feb 11;(24):846–854.
   PubMed Web of Science ®Google Scholar
• Lee KC, Chen YL, Lin PY, et al. Ursolic acid-induced apoptosis via regulation of the PI3K/Akt and MAPK signaling pathways in Huh-7 cells. Molecules. 2018 Aug 13;23(8).
   Web of Science ®Google Scholar
• Luo J, Hu YL, Wang H. Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/AKT and NF-κB signaling pathways in vitro. Exp Ther Med. 2017 Oct;14(4):3623–3631.
   PubMed Web of Science ®Google Scholar